(S029) Development of an Immune-Associated Molecular Signature Predicting Melanoma Survival

Goran Micevic; Viswanathan Muthusamy; Gulietta M. Pupo; Richard A Scolyer; Georgina V. Long; Marcus Bosenberg

doi:10.1016/j.ijrobp.2017.02.065

Related publications

Article2019

An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents

Agrin Moeini, Sara Torrecilla, Victoria Tovar, Carla Montironi, Carmen Andreu-Oller, Judit Peix, Mónica Higuera, Dominik Pfister, Pierluigi Ramadori, Roser Pinyol, Manel Solé, Mathias Heikenwälder, Scott L. Friedman, Daniela Sia, Josep M. Llovet

Gastroenterology

Article2011

Factors Predicting Recurrence and Survival in Sentinel Lymph Node-Positive Melanoma Patients

Rajmohan Murali, Chitra Desilva, John F. Thompson, Richard A Scolyer

Letter2009

High molecular weight-melanoma-associated antigen as a biomarker of desmoplastic melanoma

Yasufumi Goto, Takaaki Arigami, Rajmohan Murali, Richard A Scolyer, Atsushi Tanemura, Minoru Takata, Roderick R. Turner, Linhda Nguyen, Tung Nguyen, Donald L. Morton, Soldano Ferone, Dave S.�B. Hoon

Article2022

Clinicopathological Characteristics Predicting Further Recurrence and Survival Following Resection of In-Transit Melanoma Metastases

Anna Lawless, David J. Coker, Serigne Lo, Tasnia Ahmed, Richard A Scolyer, Sydney Ch’ng, Omgo E. Nieweg, Kerwin F. Shannon, Andrew J. Spillane, Jonathan R. Stretch, John F. Thompson, Robyn P.M. Saw

Article2025

Predicting colorectal cancer survival by combined c-reactive protein and tumor immune score

Tafirenyika Gwenzi, Durgesh Wankhede, Tanwei Yuan, Megha Bhardwaj, Petra Schrotz‐King, Sophie C. Anker, Ben Schöttker, Michael Hoffmeister, Hermann Brenner